NECLIFE.NS
Nectar Lifesciences Limited
NSEINREQUITY
Healthcare
DELAYED
Last price
10.47
▲ 0.18 (1.75%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
10.39
Prev close
10.29
Day high
10.90
Day low
10.05
Volume
322.01K
Market cap
$2.03B
P/E (TTM)
—
52W range
9.30 – 22.40
Day trading desk
Gap from prior close
+0.97%
Prior close 10.29
VWAP
10.45
+0.21% from price
Relative volume
2.18×
Unusually busy
Session range
8.46%
10.05 – 10.90
Position in range
49%
Mid range
ATR (14D)
0.56
5.32% of price
Prior day high
10.70
PDH
Prior day low
10.26
PDL
Bid / ask spread
—
Quote not published
Session volume
353.51K
Avg 162.49K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-4.82%
-3.5%
1M
+1.06%
-2.7%
3M
-14.67%
-17.8%
6M
-20.32%
-31.4%
YTD
-46.06%
-58.3%
1Y
-30.39%
-50.4%
3Y
-56.37%
-130.5%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on NECLIFE.NS open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
111.86M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Nov 27, 25 | Goyal (Raman) UNREPORTED |
BUY | 8.84M | — | Direct |
| Nov 27, 25 | Goyal (Sanjiv) UNREPORTED |
SELL | 8.00M | — | Direct |
| Dec 19, 24 | Goyal (Raman) Promoter |
BUY | 400.00K | $208.56K | Direct |
| Nov 14, 24 | InGain Traders LLC Institution- Corporation |
— | 2.39M | — | Direct |
| Sep 23, 24 | NSR Direct PE Mauritius LLC Institution- Corporation |
— | 26.00M | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
Goyal (Raman) |
UNREPORTED | 9.24M | Acquisition |
Goyal (Sanjiv) |
UNREPORTED | 47.85M | Sale |
InGain Traders LLC |
Institution- Corporation | 0 | Sale |
NSR Direct PE Mauritius LLC |
Institution- Corporation | 0 | Sale |
Fundamentals
Market cap$2.03B
Enterprise value$959.49M
Revenue (TTM)$92.91M
Gross profit$92.91M
EBITDA$-289.51M
Net income$-573.47M
EPS (TTM)$-3.43
Free cash flow$5.40B
Total cash$1.25B
Total debt$0
Book value / share$28.98
Shares outstanding194.26M
Float87.72M
Short % of float—
Dividend yield—
Beta (5Y)0.62
Valuation & profitability ratios
Trailing P/E—
Forward P/E3.53
PEG ratio—
Price / sales—
Price / book0.36
EV / revenue10.33
EV / EBITDA-3.31
Gross margin100.00%
Operating margin-673.19%
Profit margin0.00%
Return on equity-7.46%
Return on assets-2.42%
Debt / equity—
Current ratio9.59
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $0 | $0 | $16.84B | $15.24B | — | — |
| Operating revenue | $0 | $0 | $16.84B | $15.24B | — | — |
| Cost of revenue | $0 | $0 | $13.87B | $13.31B | — | — |
| Gross profit | $0 | $0 | $2.97B | $1.92B | — | — |
| Selling, general & admin | — | $643.91M | $561.81M | $571.50M | $618.22M | — |
| Total operating expense | $590.34M | $7.81M | $2.05B | $1.97B | — | +7,461.7% |
| Operating income | -$590.34M | -$7.81M | $923.82M | -$51.75M | — | -7,461.7% |
| Net interest income | -$361.25M | $0 | -$747.52M | -$777.61M | — | — |
| Pre-tax income | -$878.79M | $10.72M | $182.69M | -$424.20M | — | -8,296.9% |
| Tax provision | -$305.32M | $3.75M | $132.74M | -$182.37M | — | -8,250.5% |
| Net income | -$2.93B | -$1.14B | $49.95M | -$241.83M | — | -157.6% |
| Net income to common | -$2.93B | -$1.14B | $49.95M | -$241.83M | — | -157.6% |
| Basic EPS | -13.40 | -5.07 | 0.22 | -1.08 | — | -164.3% |
| Diluted EPS | -13.40 | -5.07 | 0.22 | -1.08 | — | -164.3% |
| EBIT | -$517.54M | $10.72M | $1.08B | $403.78M | — | -4,927.3% |
| EBITDA | -$289.51M | $634.62M | $1.69B | $994.97M | — | -145.6% |
| Basic shares | 218.58M | 224.22M | 224.26M | 224.26M | — | -2.5% |
| Diluted shares | 218.58M | 224.22M | 224.26M | 224.26M | — | -2.5% |
| Line item | 2026 | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.12B | $192.09M | $197.89M | $175.52M | — | +483.8% |
| Cash & short-term investments | $1.91B | $197.39M | $202.84M | $178.66M | — | +868.2% |
| Accounts receivable | $0 | $3.45B | $3.79B | $2.80B | — | -100.0% |
| Inventory | $2.98M | $6.90B | $7.09B | $6.73B | — | -100.0% |
| Total current assets | $2.53B | $12.38B | $12.84B | $12.31B | — | -79.6% |
| Property, plant & equipment | $1.03B | $6.33B | $6.56B | $6.90B | — | -83.7% |
| Goodwill & intangibles | $11.12M | $565.05M | $523.93M | $493.28M | — | -98.0% |
| Total assets | $6.22B | $20.47B | $21.91B | $21.89B | — | -69.6% |
| Total current liabilities | $301.14M | $10.22B | $9.73B | $8.91B | — | -97.1% |
| Current debt | $0 | $5.22B | $4.95B | $5.27B | — | -100.0% |
| Long-term debt | $0 | $601.27M | $1.40B | $2.26B | — | -100.0% |
| Total debt | $0 | $5.82B | $6.36B | $7.54B | — | -100.0% |
| Total liabilities | $393.11M | $10.91B | $11.22B | $11.25B | — | -96.4% |
| Retained earnings | — | $5.91B | $7.04B | $6.99B | $7.19B | — |
| Shareholder equity | $5.82B | $9.56B | $10.69B | $10.65B | — | -39.1% |
| Working capital | $2.23B | $2.16B | $3.11B | $3.40B | — | +3.2% |
| Net tangible assets | $5.81B | $9.00B | $10.17B | $10.15B | — | -35.4% |
| Shares issued | 194.26M | 224.26M | 224.26M | 224.26M | — | -13.4% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | -$7.89B | -$1.62B | $182.69M | -$424.20M | -388.4% |
| Depreciation & amortisation | $228.03M | $623.89M | $607.18M | $591.19M | -63.5% |
| Change in working capital | $2.06B | $1.92B | $688.67M | $779.26M | +7.3% |
| Operating cash flow | -$3.49B | $1.69B | $2.25B | $1.34B | -305.8% |
| Capital expenditure | -$122.74M | -$437.95M | -$294.15M | -$300.60M | +72.0% |
| Investing cash flow | $12.08B | -$419.30M | -$170.25M | $517.04M | +2,981.3% |
| Share buybacks | -$810.00M | $0 | — | — | — |
| Financing cash flow | -$7.67B | -$1.28B | -$2.05B | -$1.86B | -498.4% |
| Free cash flow | -$3.61B | $1.26B | $1.95B | $1.04B | -387.3% |
| End cash position | $1.12B | $192.22M | $198.06M | $175.80M | +483.4% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $0 | $0 | $49.97M | $2.81B | $0 | — |
| Operating revenue | $0 | $0 | $49.97M | $2.81B | $0 | — |
| Cost of revenue | $0 | $0 | $33.55M | $2.64B | $0 | — |
| Gross profit | $0 | $0 | $16.42M | $171.26M | $0 | — |
| Total operating expense | $573.18M | $19.87M | $21.75M | $955.35M | $3.40M | +2,785.3% |
| Operating income | -$573.18M | -$19.87M | -$5.32M | -$784.09M | -$3.40M | -2,785.3% |
| Net interest income | -$59.01M | -$302.25M | $0 | -$186.95M | $0 | +80.5% |
| Pre-tax income | -$569.29M | $566.01M | -$5.06M | -$967.54M | -$1.63M | -200.6% |
| Tax provision | -$197.16M | -$110.25M | -$1.77M | -$335.24M | -$571.00K | -78.8% |
| Net income | -$679.24M | $142.70M | -$3.29M | -$632.31M | -$1.30B | -576.0% |
| Net income to common | -$679.24M | $142.70M | -$3.29M | -$632.31M | -$1.30B | -576.0% |
| Basic EPS | -3.38 | 0.64 | -7.85 | -2.82 | -5.80 | -628.1% |
| Diluted EPS | -3.38 | 0.64 | -7.85 | -2.82 | -5.80 | -628.1% |
| EBIT | -$510.28M | $868.25M | -$5.06M | -$780.59M | -$1.63M | -158.8% |
| EBITDA | -$509.45M | $868.87M | -$3.02M | -$615.43M | $1.37M | -158.6% |
| Basic shares | 200.96M | 222.96M | 224.26M | 224.22M | 224.29M | -9.9% |
| Diluted shares | 200.96M | 222.96M | 224.26M | 224.22M | 224.29M | -9.9% |
| Line item | 2026-03-31 | 2025-09-30 | 2025-03-31 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $1.12B | $59.30M | $192.09M | +1,790.9% |
| Cash & short-term investments | $1.91B | $139.72M | $197.39M | +1,267.8% |
| Accounts receivable | $0 | $542.96M | $3.45B | -100.0% |
| Inventory | $2.98M | $29.83M | $6.90B | -90.0% |
| Total current assets | $2.53B | $2.59B | $12.38B | -2.3% |
| Property, plant & equipment | $1.03B | $275.91M | $6.33B | +274.8% |
| Goodwill & intangibles | $11.12M | $0 | $565.05M | — |
| Total assets | $6.22B | $18.15B | $20.47B | -65.7% |
| Total current liabilities | $301.14M | $10.85B | $10.22B | -97.2% |
| Current debt | $0 | $4.46B | $5.22B | -100.0% |
| Long-term debt | $0 | $133.14M | $601.27M | -100.0% |
| Total debt | $0 | $4.59B | $5.82B | -100.0% |
| Total liabilities | $393.11M | $10.98B | $10.91B | -96.4% |
| Retained earnings | — | — | $5.91B | — |
| Shareholder equity | $5.82B | $7.17B | $9.56B | -18.8% |
| Working capital | $2.23B | -$8.26B | $2.16B | +127.0% |
| Net tangible assets | $5.81B | $7.17B | $9.00B | -18.9% |
| Shares issued | 194.26M | 224.26M | 224.26M | -13.4% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Mar 2018 | 0.90 | 0.17 | -81.1% |
| Dec 2017 | — | 0.85 | — |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders55.66%
Held by institutions0.00%
Institutions holding3
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
10.74
-2.51% from price
SMA 20
10.60
-1.18% from price
SMA 50
11.02
-4.95% from price
SMA 100
11.57
-9.51% from price
SMA 200
13.39
-21.83% from price
EMA 12
10.66
-1.76% from price
EMA 26
10.74
-2.55% from price
EMA 50
11.00
-4.84% from price
RSI (14)
44.7
Neutral
MACD (12,26,9)
-0.09
Hist 0.01
ATR (14)
0.56
5.32% of price
Realised vol 30D
32.0%
Annualised
Bollinger upper
11.21
20, 2σ
Bollinger lower
9.98
20, 2σ
50 / 200 cross
Death
11.02 vs 13.39
Trend bias
Below 200
-21.83%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.63
Less volatile than market
Correlation to SPY
0.16
Largely independent
Realised vol 30D
32.0%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-58.2%
Peak to trough
Max drawdown 5Y
-82.8%
Peak to trough
ATR 14
0.56
5.32% of price
Beta (reported)
0.62
5Y monthly, from filing
Dividends & splits
Forward rate—
Forward yield—
5-year avg yield0.27%
Payout ratio0.00%
Ex-dividend dateSep 21, 2020
Next pay date—
Last split10:1
Split dateNov 12, 2008
Headlines
What Happens When Social Security Takes Your Benefits Because You Work Too Much?
Motley Fool · 9m ago
Carney warned about economic coercion. Now Trump is testing the Canadian prime minister
Associated Press · 17m ago
Alibaba Launches Record $10 Billion Share Sale to Enter the AI Race
BeInCrypto · 20m ago
Pershing Square (PS) Following Earnings Loss And New Venture Launch Faces A Valuation Test
Simply Wall St. · 21m ago
Tenet Healthcare (THC) Stock May Be 49% Undervalued After Raised Outlook
Simply Wall St. · 21m ago
Morgan Housel warns of a looming career threat for your child
TheStreet · 22m ago
History Says You Should Know These 3 Things Before Buying the Vanguard S&P 500 ETF (VOO)
Motley Fool · 24m ago
He Camped One Weekend on Riverfront Land Inside His IRA. Medicare Charged Him for It Two Years Later.
24/7 Wall St. · 26m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.